IPO

China Feihe’s $1.1b IPO goes for prudent pricing strategy

Listing against the backdrop of social unrest in Hong Kong, China’s largest infant milk formula maker stays cautious with pricing and leaves something on the table for prospective investors.

Infant milk formula manufacturer China Feihe is poised to give the Hong Kong stock exchange another boost following the revival of two billion-dollar flotations earlier this year, assuming it completes an initial public offering of up to HK$8.9 billion ($1.1 billion) next week.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media